Patricia Zuchowicz received a Naval Hospital prescription directing her to take 1,600 milligrams of Danocrine daily—twice the FDA-approved maximum dose of 800 milligrams. The United States stipulated that its physicians or pharmacists were negligent in prescribing that dosage. After taking the overdose for about a month, and then 800 milligrams daily for roughly two more months, Zuchowicz developed symptoms including edema, fatigue, chest pain, and shortness of breath.
In October 1989, Zuchowicz was diagnosed with primary pulmonary hypertension (PPH), a rare and usually fatal disease. She died in December 1991. Her husband, Steven Zuchowicz, continued the Federal Tort Claims Act action on behalf of her estate, alleging that the Danocrine overdose caused her PPH and death.
After a bench trial, the District of Connecticut admitted testimony from Dr. Richard Matthay, a pulmonary specialist who treated Zuchowicz, and Dr. Randall Tackett, a pharmacologist. The court found that the overdose more likely than not caused Zuchowicz's disease and awarded $1,034,286.02 in damages. The United States appealed the admission of the experts' testimony, the causation finding, and the lost-earnings award; the estate cross-appealed the amount of noneconomic damages.
Issue #1
Whether the district court abused its discretion under Federal Rule of Evidence 702 and Daubert by admitting the testimony of Drs. Matthay and Tackett.
Holding
No. The district court did not abuse its discretion, much less commit manifest error, in admitting the experts' testimony.
Reasoning
Daubert requires the trial judge to act as a gatekeeper by making a preliminary assessment that expert testimony rests on reliable scientific reasoning or methodology and fits the facts at issue. Its listed considerations—testability, peer review, error rate, and general acceptance—are flexible guideposts rather than a rigid checklist. Appellate review of the district court's evidentiary ruling is highly deferential.
Dr. Matthay and Dr. Tackett were well-qualified experts who used methods reasonably relied upon in their respective fields. Matthay based his conclusion on his treatment of Zuchowicz, her medical history, the timing and progression of her symptoms, differential etiology, and his experience with drug-induced pulmonary disease. Tackett drew on pharmacological evidence concerning the hormonal effects of Danocrine and the mechanisms that could produce endothelial dysfunction.
The government's attacks on the experts' credentials, their applications of differential etiology, and the strength of the scientific support went to the weight of their testimony rather than its admissibility. The district court had carefully considered those objections and permissibly concluded that the testimony was sufficiently reliable to assist the factfinder.
Issue #2
Whether the evidence supported the finding that Danocrine was, more likely than not, a but-for cause of Zuchowicz's primary pulmonary hypertension and death.
Holding
Yes. Dr. Matthay's testimony provided an adequate evidentiary basis for the district court's finding that Danocrine caused Zuchowicz's PPH.
Reasoning
Under Connecticut law, a medical-malpractice plaintiff must prove that the defendant's negligence was a substantial factor in producing the injury. That ordinarily entails showing but-for causation, a causal link between the negligent conduct and the harm, and proximate cause. Here, the disputed question was but-for causation, not proximate cause or causal link.
Connecticut requires expert causation testimony to establish reasonable medical probability rather than speculation, but it permits proof through circumstantial evidence and differential diagnosis. An expert need not eliminate every theoretical cause if the evidence supports the conclusion that the defendant's conduct was more likely than not the cause.
Matthay excluded the known causes of secondary pulmonary hypertension and the previously known drug-related causes of PPH. He also testified that Zuchowicz had been healthy before taking Danocrine and developed symptoms characteristic of drug-induced PPH shortly after the overdose. The relatively close timing between exposure and symptoms, unlike a toxic-tort case involving a lengthy latency period, reinforced the district court's finding that Danocrine more probably than not caused her illness.
Issue #3
Whether the evidence supported the further finding that the negligent overdose, rather than Danocrine at a proper dose, was a but-for cause of Zuchowicz's injury.
Holding
Yes. The factfinder could conclude that the excessive, unapproved dosage was a substantial factor in causing Zuchowicz's PPH and death.
Reasoning
Proof that Danocrine caused the illness did not by itself establish liability, because the government's conceded negligence was prescribing twice the approved maximum dose. The estate also had to show, by a preponderance of the evidence, that the overdose itself caused the injury.
The court applied the principle that when conduct is negligent precisely because it increases the risk of a particular kind of harm, and that very harm occurs, the factfinder may infer that the negligence caused it. This principle is reflected in cases such as Martin v. Herzog and is accepted under Connecticut law. The defendant may rebut the inference with evidence that the violation did not actually contribute to the injury in the particular case.
FDA dosage limits exist because drugs carry risks of harmful side effects and higher doses generally increase those risks, including unknown risks. Thus, once the evidence showed that Danocrine caused Zuchowicz's adverse condition, the prescription of an unapproved dosage twice the tested maximum strongly supported an inference that the overdose caused it. Matthay supplied additional direct support by testifying that the timing of the illness indicated a catastrophic reaction to the overdose, not merely to ordinary Danocrine use.
Issue #4
Whether the district court lacked support for its award of lost earnings and earning capacity.
Holding
No. The lost-earnings award was supported by facts the parties had agreed upon before trial.
Reasoning
Before trial, the government proposed, and the estate accepted, findings concerning Zuchowicz's earnings as a nurse's aide in 1987 and 1988. The district court was entitled to rely on those agreed facts in calculating lost earnings and earning capacity.
A pretrial agreement on an undisputed fact narrows the issues to be proved at trial. The government could not later object that the agreed earnings figures had not independently been proven at trial.
Issue #5
Whether the district court's $900,000 award of noneconomic damages was so inadequate that additur was required.
Holding
No. The noneconomic-damages award was within the permissible range of appropriate awards.
Reasoning
The estate argued on cross-appeal that $900,000 did not adequately reflect the severity of Zuchowicz's suffering and loss. The court concluded, however, that the district court's valuation fell within the range of reasonable awards and therefore gave no basis for appellate intervention.